Comparison Chart Adial Pharmaceuticals, Inc.
Stocks
ADIL
US00688A3041
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 5.050 USD | +36.12% |
|
+22.87% | -8.18% |
| 10-16 | Adial Pharmaceuticals, Inc. Announces Appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist | CI |
| 09-18 | Adial Pharmaceuticals Announces Board Appointments | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +36.12% | +22.87% | -8.18% | -46.48% | -99.76% | 9.74M |  | |  |
- Stock Market
- Stocks
- ADIL Stock
- Charts Adial Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
